Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katsuya Shiraki MD, PhD"'
Autor:
Shunsuke Fukui MD, Hideo Wada MD, PhD, Kohei Ikeda MD, Mayu Kobayashi MD, Yasuaki Shimada MD, Yuuichi Nakazawa MD, Hiroki Mizutani MD, Yuhuko Ichikawa, Yuuki Nishiura MD, Isao Moritani MD, PhD, Yutaka Yamanaka MD, Hidekazu Inoue MD, PhD, Motomu Shimaoka MD, PhD, Hideto Shimpo MD, PhD, Katsuya Shiraki MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 30 (2024)
Background: Although hepatocellular carcinoma (HCC) is frequently associated with thrombosis, it is also associated with liver cirrhosis (LC) which causes hemostatic abnormalities. Therefore, hemostatic abnormalities in patients with HCC were examine
Externí odkaz:
https://doaj.org/article/eae6b982e68a4eae922ff717ba94ffd5
Autor:
Toshitaka Kamon MD, Hideo Wada MD, PhD, Shotaro Horie MD, Tomoya Inaba MD, Karin Okamoto MD, Katsuya Shiraki MD, PhD, Yuhuko Ichikawa, Minoru Ezaki, Motomu Shimaoka MD, PhD, Akisato Nishigaki MD, Akihiro Shindo MD, PhD, Hideto Shimpo MD, PhD, Nobuo Ito MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 30 (2024)
Acute cerebral infarction (ACI) includes atherosclerotic and cardiogenic ACI and involves a thrombotic state, requiring antithrombotic treatment. However, the thrombotic state in ACI cannot be evaluated using routine hemostatic examinations. Plasma s
Externí odkaz:
https://doaj.org/article/c6b77432d88b4eb9a9bf1d5bcc06fc74
Autor:
Hideo Wada MD, PhD, Katsuya Shiraki MD, PhD, Takeshi Matsumoto MD, PhD, Kohshi Ohishi MD, PhD, Hideto Shimpo MD, PhD, Yumi Sakano Mrs, Hiroko Nishii Mrs, Motomu Shimaoka MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
The FVIII activity in patients treated with several extended half-life FVIII (EHL-FVIII) agents different when various activated partial thromboplastin time (APTT) reagents were used. The present study examined the difference in clot waveform analysi
Externí odkaz:
https://doaj.org/article/d6eccec4ac7c45dcafbd30ebab5ab8bd
Autor:
Yuhuko Ichkawa Ms, Hideo Wada MD, PhD, Minoru Ezaki Mr, Motoko Tanaka, Shinya Hiromori, Katsuya Shiraki MD, PhD, Isao Moritani MD, PhD, Akitaka Yamamoto MD, PhD, Haruhiko Tashiro MD, PhD, Hideto Shimpo MD, PhD, Motomu Shimaoka
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
D-dimer is a biomarker of thrombosis and recently been considered to predict a poor outcome in patients with infectious diseases. Plasma D-dimer levels were measured in critically ill patients to examine their relationship with the poor outcome. The
Externí odkaz:
https://doaj.org/article/6d99548f905d458a95999f7484994c16
Autor:
Hideo Wada MD, PhD, Takeshi Matsumoto MD, PhD, Kohshi Ohishi MD, PhD, Katsuya Shiraki MD, PhD, Motomu Shimaoka MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
The activated partial thromboplastin time (APTT)–clot waveform analysis (CWA) was previously reported to be associated with the early detection of disseminated intravascular coagulation and was also reported to be able to measure very low levels of
Externí odkaz:
https://doaj.org/article/04060aaa60684755b38fd45644f250d5